Glypressin Stungulyf, lausn 0,1 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

glypressin stungulyf, lausn 0,1 mg/ml

ferring lægemidler a/s - terlipressinum acetat - stungulyf, lausn - 0,1 mg/ml

Glypressin Stungulyfsstofn og leysir, lausn 1 mg/hgl. Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

glypressin stungulyfsstofn og leysir, lausn 1 mg/hgl.

ferring lægemidler a/s - terlipressinum acetat - stungulyfsstofn og leysir, lausn - 1 mg/hgl.

Citanest Dental Octapressin Stungulyf, lausn 30 mg+0,54 míkróg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

citanest dental octapressin stungulyf, lausn 30 mg+0,54 míkróg/ml

dentsply detrey gmbh* - prilocainum hýdróklóríð; felypressinum inn - stungulyf, lausn - 30 mg+0,54 míkróg/ml

Paxlovid Evrópusambandið - íslenska - EMA (European Medicines Agency)

paxlovid

pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.

Zokinvy Evrópusambandið - íslenska - EMA (European Medicines Agency)

zokinvy

eigerbio europe limited - lonafarnib - progeria; laminopathies - Önnur meltingarvegi og efnaskipti vörur, - zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of hutchinson-gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous lmna mutation with progerin-like protein accumulation or a homozygous or compound heterozygous zmpste24 mutation.